Prominent phenotypic variability associated with mutations in Progranulin

Brendan J. Kelley; Wael Haidar; Bradley F. Boeve; Matt Baker; Neill R. Graff-Radford; Thomas Krefft; Andrew R. Frank; Clifford R. Jack; Maria Shiung; David S. Knopman; Keith A. Josephs; Sotirios A. Parashos; Rosa Rademakers; Mike Hutton; Stuart Pickering-Brown; Jennifer Adamson; Karen M. Kuntz; Dennis W. Dickson; Joseph E. Parisi; Glenn E. Smith; Robert J. Ivnik; Ronald C. Petersen

doi:10.1016/j.neurobiolaging.2007.08.022

Prominent phenotypic variability associated with mutations in Progranulin

Brendan J. Kelley, Wael Haidar, Bradley F. Boeve, Matt Baker, Neill R. Graff-Radford, Thomas Krefft, Andrew R. Frank, Clifford R. Jack, Maria Shiung, David S. Knopman, Keith A. Josephs, Sotirios A. Parashos, Rosa Rademakers, Mike Hutton, Stuart Pickering-Brown, Jennifer Adamson, Karen M. Kuntz, Dennis W. Dickson, Joseph E. Parisi, Glenn E. SmithRobert J. Ivnik, Ronald C. Petersen

Research output: Contribution to journal › Article › peer-review

154 Scopus citations

Abstract

Mutations in progranulin (PGRN) are associated with frontotemporal dementia with or without parkinsonism. We describe the prominent phenotypic variability within and among eight kindreds evaluated at Mayo Clinic Rochester and/or Mayo Clinic Jacksonville in whom mutations in PGRN were found. All available clinical, genetic, neuroimaging and neuropathologic data was reviewed. Age of onset ranged from 49 to 88 years and disease duration ranged from 1 to 14 years. Clinical diagnoses included frontotemporal dementia (FTD), primary progressive aphasia, FTD with parkinsonism, parkinsonism, corticobasal syndrome, Alzheimer's disease, amnestic mild cognitive impairment, and others. One kindred exhibited maximal right cerebral hemispheric atrophy in all four affected individuals, while another had maximal left hemisphere involvement in all three of the affected. Neuropathologic examination of 13 subjects revealed frontotemporal lobar degeneration with ubiquitin-positive inclusions plus neuronal intranuclear inclusions in all cases. Age of onset, clinical phenotypes and MRI findings associated with most PGRN mutations varied significantly both within and among kindreds. Some kindreds with PGRN mutations exhibited lateralized topography of degeneration across all affected individuals.

Original language	English (US)
Pages (from-to)	739-751
Number of pages	13
Journal	Neurobiology of Aging
Volume	30
Issue number	5
DOIs	https://doi.org/10.1016/j.neurobiolaging.2007.08.022
State	Published - May 2009

Bibliographical note

Funding Information:
This research is supported by National Institute on Aging grants AG06786, AG16574, AG11378 and AG07216, and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation. RR is a postdoctoral fellow from the Fund for Scientific Research Flanders (FWO-F). We thank the Mayo Clinic Alzheimer's Disease Research Center staff for their assistance in evaluating the subjects. We particularly thank the members of these eight families for participating in neurodegenerative disease research.

Keywords

FTDP-17
Frontotemporal dementia
MRI
PGRN
Progranulin

Publisher link

10.1016/j.neurobiolaging.2007.08.022

Find It

Find It at U of M Libraries

Cite this

Kelley, B. J., Haidar, W., Boeve, B. F., Baker, M., Graff-Radford, N. R., Krefft, T., Frank, A. R., Jack, C. R., Shiung, M., Knopman, D. S., Josephs, K. A., Parashos, S. A., Rademakers, R., Hutton, M., Pickering-Brown, S., Adamson, J., Kuntz, K. M., Dickson, D. W., Parisi, J. E., ... Petersen, R. C. (2009). Prominent phenotypic variability associated with mutations in Progranulin. Neurobiology of Aging, 30(5), 739-751. https://doi.org/10.1016/j.neurobiolaging.2007.08.022

Kelley, BJ, Haidar, W, Boeve, BF, Baker, M, Graff-Radford, NR, Krefft, T, Frank, AR, Jack, CR, Shiung, M, Knopman, DS, Josephs, KA, Parashos, SA, Rademakers, R, Hutton, M, Pickering-Brown, S, Adamson, J, Kuntz, KM, Dickson, DW, Parisi, JE, Smith, GE, Ivnik, RJ & Petersen, RC 2009, 'Prominent phenotypic variability associated with mutations in Progranulin', Neurobiology of Aging, vol. 30, no. 5, pp. 739-751. https://doi.org/10.1016/j.neurobiolaging.2007.08.022

@article{d5ae454849ae4d4981bba146292f5d87,

title = "Prominent phenotypic variability associated with mutations in Progranulin",

abstract = "Mutations in progranulin (PGRN) are associated with frontotemporal dementia with or without parkinsonism. We describe the prominent phenotypic variability within and among eight kindreds evaluated at Mayo Clinic Rochester and/or Mayo Clinic Jacksonville in whom mutations in PGRN were found. All available clinical, genetic, neuroimaging and neuropathologic data was reviewed. Age of onset ranged from 49 to 88 years and disease duration ranged from 1 to 14 years. Clinical diagnoses included frontotemporal dementia (FTD), primary progressive aphasia, FTD with parkinsonism, parkinsonism, corticobasal syndrome, Alzheimer's disease, amnestic mild cognitive impairment, and others. One kindred exhibited maximal right cerebral hemispheric atrophy in all four affected individuals, while another had maximal left hemisphere involvement in all three of the affected. Neuropathologic examination of 13 subjects revealed frontotemporal lobar degeneration with ubiquitin-positive inclusions plus neuronal intranuclear inclusions in all cases. Age of onset, clinical phenotypes and MRI findings associated with most PGRN mutations varied significantly both within and among kindreds. Some kindreds with PGRN mutations exhibited lateralized topography of degeneration across all affected individuals.",

keywords = "FTDP-17, Frontotemporal dementia, MRI, PGRN, Progranulin",

author = "Kelley, {Brendan J.} and Wael Haidar and Boeve, {Bradley F.} and Matt Baker and Graff-Radford, {Neill R.} and Thomas Krefft and Frank, {Andrew R.} and Jack, {Clifford R.} and Maria Shiung and Knopman, {David S.} and Josephs, {Keith A.} and Parashos, {Sotirios A.} and Rosa Rademakers and Mike Hutton and Stuart Pickering-Brown and Jennifer Adamson and Kuntz, {Karen M.} and Dickson, {Dennis W.} and Parisi, {Joseph E.} and Smith, {Glenn E.} and Ivnik, {Robert J.} and Petersen, {Ronald C.}",

note = "Funding Information: This research is supported by National Institute on Aging grants AG06786, AG16574, AG11378 and AG07216, and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation. RR is a postdoctoral fellow from the Fund for Scientific Research Flanders (FWO-F). We thank the Mayo Clinic Alzheimer's Disease Research Center staff for their assistance in evaluating the subjects. We particularly thank the members of these eight families for participating in neurodegenerative disease research.",

year = "2009",

month = may,

doi = "10.1016/j.neurobiolaging.2007.08.022",

language = "English (US)",

volume = "30",

pages = "739--751",

journal = "Neurobiology of Aging",

issn = "0197-4580",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Prominent phenotypic variability associated with mutations in Progranulin

AU - Kelley, Brendan J.

AU - Haidar, Wael

AU - Boeve, Bradley F.

AU - Baker, Matt

AU - Graff-Radford, Neill R.

AU - Krefft, Thomas

AU - Frank, Andrew R.

AU - Jack, Clifford R.

AU - Shiung, Maria

AU - Knopman, David S.

AU - Josephs, Keith A.

AU - Parashos, Sotirios A.

AU - Rademakers, Rosa

AU - Hutton, Mike

AU - Pickering-Brown, Stuart

AU - Adamson, Jennifer

AU - Kuntz, Karen M.

AU - Dickson, Dennis W.

AU - Parisi, Joseph E.

AU - Smith, Glenn E.

AU - Ivnik, Robert J.

AU - Petersen, Ronald C.

N1 - Funding Information: This research is supported by National Institute on Aging grants AG06786, AG16574, AG11378 and AG07216, and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation. RR is a postdoctoral fellow from the Fund for Scientific Research Flanders (FWO-F). We thank the Mayo Clinic Alzheimer's Disease Research Center staff for their assistance in evaluating the subjects. We particularly thank the members of these eight families for participating in neurodegenerative disease research.

PY - 2009/5

Y1 - 2009/5

N2 - Mutations in progranulin (PGRN) are associated with frontotemporal dementia with or without parkinsonism. We describe the prominent phenotypic variability within and among eight kindreds evaluated at Mayo Clinic Rochester and/or Mayo Clinic Jacksonville in whom mutations in PGRN were found. All available clinical, genetic, neuroimaging and neuropathologic data was reviewed. Age of onset ranged from 49 to 88 years and disease duration ranged from 1 to 14 years. Clinical diagnoses included frontotemporal dementia (FTD), primary progressive aphasia, FTD with parkinsonism, parkinsonism, corticobasal syndrome, Alzheimer's disease, amnestic mild cognitive impairment, and others. One kindred exhibited maximal right cerebral hemispheric atrophy in all four affected individuals, while another had maximal left hemisphere involvement in all three of the affected. Neuropathologic examination of 13 subjects revealed frontotemporal lobar degeneration with ubiquitin-positive inclusions plus neuronal intranuclear inclusions in all cases. Age of onset, clinical phenotypes and MRI findings associated with most PGRN mutations varied significantly both within and among kindreds. Some kindreds with PGRN mutations exhibited lateralized topography of degeneration across all affected individuals.

AB - Mutations in progranulin (PGRN) are associated with frontotemporal dementia with or without parkinsonism. We describe the prominent phenotypic variability within and among eight kindreds evaluated at Mayo Clinic Rochester and/or Mayo Clinic Jacksonville in whom mutations in PGRN were found. All available clinical, genetic, neuroimaging and neuropathologic data was reviewed. Age of onset ranged from 49 to 88 years and disease duration ranged from 1 to 14 years. Clinical diagnoses included frontotemporal dementia (FTD), primary progressive aphasia, FTD with parkinsonism, parkinsonism, corticobasal syndrome, Alzheimer's disease, amnestic mild cognitive impairment, and others. One kindred exhibited maximal right cerebral hemispheric atrophy in all four affected individuals, while another had maximal left hemisphere involvement in all three of the affected. Neuropathologic examination of 13 subjects revealed frontotemporal lobar degeneration with ubiquitin-positive inclusions plus neuronal intranuclear inclusions in all cases. Age of onset, clinical phenotypes and MRI findings associated with most PGRN mutations varied significantly both within and among kindreds. Some kindreds with PGRN mutations exhibited lateralized topography of degeneration across all affected individuals.

KW - FTDP-17

KW - Frontotemporal dementia

KW - MRI

KW - PGRN

KW - Progranulin

UR - http://www.scopus.com/inward/record.url?scp=62349102691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62349102691&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2007.08.022

DO - 10.1016/j.neurobiolaging.2007.08.022

M3 - Article

C2 - 17949857

AN - SCOPUS:62349102691

SN - 0197-4580

VL - 30

SP - 739

EP - 751

JO - Neurobiology of Aging

JF - Neurobiology of Aging

IS - 5

ER -

Prominent phenotypic variability associated with mutations in Progranulin

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this